Cargando…
Conditional reprogramming technology: a new tool for personalized medicine in bladder cancer?
Autor principal: | Miyamoto, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797928/ https://www.ncbi.nlm.nih.gov/pubmed/35117148 http://dx.doi.org/10.21037/tcr.2019.12.20 |
Ejemplares similares
-
N-Myc-mediated epigenetic reprogramming in advanced prostate cancer: personalized medicine and quality of biological samples
por: Bettuzzi, Saverio
Publicado: (2019) -
Behind a personalized therapy with immune check-point inhibitors in metastatic bladder cancer: ready for a primetime?
por: Poletajew, Sławomir, et al.
Publicado: (2020) -
New Technologies for Personalized Medicine in Head and Neck Oncologic and Reconstructive Surgery
por: Cebrián Carretero, José Luis, et al.
Publicado: (2022) -
Translating Metabolic Reprogramming into New Targets for Kidney Cancer
por: Abu Aboud, Omran, et al.
Publicado: (2017) -
Personalizing Medicine and Technologies to Address the Experiences and Needs of People with Multiple Sclerosis
por: Henschke, Adam, et al.
Publicado: (2021)